Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

NCT06834165 is registered in ClinicalTrials.gov with ARS Pharmaceuticals, Inc. as lead sponsor.

NCT NCT06834165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06834165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Lead sponsor
ARS Pharmaceuticals, Inc.
Phase
Phase 4
Overall status
Recruiting
Start date
May 20, 2025
Completion date
June 30, 2027
Enrollment
600 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

allergic reactions